Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CTRE vs FITZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTRE Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

CTRE Overall Winner 6-Pillar Tally: CTRE 6 – 0 FITZ Matrix Metrics: CTRE 8 – 2 FITZ

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over FITZ (FITZ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 55.4/100 (HOLD) at $37.39 (19.7x Forward P/E, 66.2% operating margin), whereas FITZ carries 57.6/100 (HOLD) at $25.44 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While FITZ currently prints a higher short-term Unified Composite Score (57.6/100 HOLD vs. CTRE 55.4/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (66.2% vs. N/A operating margin) and revenue trajectory (+33.2% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CTRE vs FITZ
CTRE NYSE Head-to-Head Winner
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.39
-1.79% 1D
Market Cap $9.8B
TTM Revenue $615M
Forward P/E 19.7x
Beta / 30D Vol 0.15β · 28% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 42.0 Fund 48.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.3 · SMA20: $37.15 · SMA50: $37.17
FITZ US Equity
FITZ
Institutional Equity
$25.44
-2.15% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.00β · 27% Vol
Unified Composite Score
57.6 / 100 HOLD
Tech 45.0 Fund 59.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 43
RSI-14: 43.0 · SMA20: $26.09 · SMA50: $25.92

6-Pillar Scorecard Institutional Category Breakdown (CTRE 6 – 0 FITZ)

Columns: Metric · CTRE · FITZ
1. Valuation Multiples CTRE
Forward P/E 19.7x N/M
Trailing P/E 23.9x N/M
PEG Ratio 1.26x N/M
EV / Revenue 18.5x N/M
2. Growth & Scale CTRE
Revenue Growth (YoY) +33.2% N/A
Earnings Growth (YoY) -0.8% N/A
TTM Revenue (USD) $615M N/A
Market Cap $9.8B N/A
3. Profitability & Quality CTRE
Gross Margin 95.7% N/A
Operating Margin 66.2% N/A
Net Profit Margin 59.2% N/A
Return on Equity (ROE) 7.7% N/A
4. Balance Sheet & Cash Flow CTRE
Cash Generation (TTM) $485M N/A
Cash Flow Margin 78.8% N/A
Net Cash / Leverage $1.59B Net Debt (0.39x D/E) N/A ROE
Dividend Yield 3.94% None (0.00%)
5. Options & Positioning CTRE
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 25.1% (11th %ile) N/A (N/A)
Put/Call OI Skew 6.12x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CTRE
OpEx & R&D Intensity 29.5% of Rev ($182M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Healthcare Facilities Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CTRE (8) vs FITZ (2)
Institutional Metric CTRE FITZ Criterion Row Edge
Market Capitalization
Scale
$9.8B N/A Larger Scale CTRE
Trailing P/E Ratio
Valuation
23.9x N/M Lower Multiple CTRE
Forward P/E Ratio
Valuation
19.7x N/M Lower Multiple CTRE
Revenue Growth (YoY)
Growth
+33.2% N/A Higher Growth CTRE
Operating Margin (TTM)
Profitability
66.2% N/A Higher Margin CTRE
Net Profit Margin
Profitability
59.2% N/A Higher Margin CTRE
Return on Equity (ROE)
Capital Efficiency
7.7% N/A Higher ROE CTRE
52-Week Range Position
Momentum
30% ($35–$44) 16% ($23–$36) Stronger Trend CTRE
Beta / 30D Volatility
Risk Regime
0.15β · 28% Vol 1.00β · 27% Vol Lower Realized Risk FITZ
Unified Institutional Score
Composite Signal
55.4 / 100 (HOLD) 57.6 / 100 (HOLD) Higher Composite FITZ
Trailing 12M Revenue (USD)
Operating Scale
$615M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.26x PEG · 18.5x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$485M ($1.59B Net Debt (0.39x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CTRE +4.04 pp
CTRE: +2.3% · FITZ: -1.74%
3M Horizon FITZ +3.96 pp
CTRE: -4.86% · FITZ: -0.9%
6M Horizon FITZ +9.85 pp
CTRE: -9.34% · FITZ: +0.51%
1Y Horizon FITZ +9.85 pp
CTRE: -9.34% · FITZ: +0.51%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CTRE vs FITZ. Trailing 12-month operating profitability (CTRE 66.2% vs FITZ N/A) and valuation multiples (CTRE 19.7x vs FITZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CTRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$615M
Gross Margin95.7%
Op. Margin66.2%
ROE / Fwd P/E7.7% · 19.7x
FITZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CTRE CONSOLIDATION
83d in phase · OBV DISTRIBUTION
Current IV 25.1%
IV Percentile 11th %ile
Put/Call OI Skew 6.12x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact CTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FITZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FITZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CTRE Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment 29.5% of Rev ($182M)
90D Engineering Disclosures 0 Published
FITZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CTRE vs FITZ Key Questions & Quantitative Answers

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over FITZ (FITZ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 55.4/100 (HOLD) at $37.39 (19.7x Forward P/E, 66.2% operating margin), whereas FITZ carries 57.6/100 (HOLD) at $25.44 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While FITZ currently prints a higher short-term Unified Composite Score (57.6/100 HOLD vs. CTRE 55.4/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (66.2% vs. N/A operating margin) and revenue trajectory (+33.2% vs. N/A YoY).

CTRE leads the Growth & Scale pillar: CTRE posts +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin), compared with FITZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CTRE generates $615M in USD-normalized revenue versus N/A for FITZ. In operating R&D and SG&A reinvestment, CTRE deploys 29.5% of Rev ($182M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FITZ.

CTRE screens cheaper on headline valuation multiples. CTRE trades at 19.7x Forward P/E, 23.9x Trailing P/E, 1.26x PEG, and 18.5x EV/Revenue (78.8% FCF margin), whereas FITZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTRE (7.7% ROE) versus FITZ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CTRE carries 25.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.15β · 28% Vol realized risk). By comparison, FITZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.00β · 27% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.